Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
Citius Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: December 20, 2019
Citius Pharmaceuticals reported fiscal year 2019 executive compensation information on December 20, 2019.
In 2019, three executives at Citius Pharmaceuticals received on average a compensation package of $588K, a 15% increase compared to previous year.
Myron Holubiak, Chief Executive Officer, received $764K in total, which increased by 12% compared to 2018. 59% of Holubiak's compensation, or $450K, was in salary. Holubiak also received $205K in non-equity incentive plan and $109K in option awards.
Jaime Bartushak, Chief Financial Officer, received a compensation package of $526K, which increased by 14% compared to previous year. 55% of the compensation package, or $290K, was in salary.
Leonard Mazur, Chairman, earned $473K in 2019, a 19% increase compared to previous year.
Citius Pharmaceuticals' fiscal year ends on September 30.